Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia-Reference-Cited by-同舟云学术

Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia

Published:2011-02-23 Issue:7339 Volume:471 Page:499-503
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Vacic Vladimir,McCarthy Shane,Malhotra Dheeraj,Murray Fiona,Chou Hsun-Hua,Peoples Aine,Makarov Vladimir,Yoon Seungtai,Bhandari Abhishek,Corominas Roser,Iakoucheva Lilia M.,Krastoshevsky Olga,Krause Verena,Larach-Walters Verónica,Welsh David K.,Craig David,Kelsoe John R.,Gershon Elliot S.,Leal Suzanne M.,Aquila Marie Dell,Morris Derek W.,Gill Michael,Corvin Aiden,Insel Paul A.,McClellan Jon,King Mary-Claire,Karayiorgou Maria,Levy Deborah L.,DeLisi Lynn E.,Sebat Jonathan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09884.pdf

Reference30 articles.

1. Sebat, J., Levy, D. L. & McCarthy, S. E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25, 528–535 (2009)

2. The International Schizophrenia Consortium . Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237–241 (2008)

3. Mulle, J. G. et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am. J. Hum. Genet. 87, 229–236 (2010)

4. Karayiorgou, M. et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl Acad. Sci. USA 92, 7612–7616 (1995)

5. McCarthy, S. E. et al. Microduplications of 16p11.2 are associated with schizophrenia. Nature Genet. 41, 1223–1227 (2009)

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copy-number variants differ in frequency across genetic ancestry groups;Human Genetics and Genomics Advances;2024-10

2. An intricate relationship between circadian rhythm dysfunction and psychiatric diseases;Exploration of Neuroscience;2024-08-23

3. KS‐133/KS‐487 Nanoparticles Exhibit Potent Antitumor Effects through Synergistic LRP1 Targeting and VIPR2 Inhibition: Therapeutic Nanoarchitectonics for Solid Tumors;Advanced Therapeutics;2024-08-02

4. Cyclic Peptides KS-133 and KS-487 Multifunctionalized Nanoparticles Enable Efficient Brain Targeting for Treating Schizophrenia;JACS Au;2024-06-20

5. CWAS-Plus: estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data;Briefings in Bioinformatics;2024-05-23